 Phuong Le
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 11 | 2023 | 425 | 1.550 |
Why?
| | Neoplastic Stem Cells | 6 | 2020 | 330 | 1.130 |
Why?
| | Carcinoma, Squamous Cell | 8 | 2019 | 577 | 1.070 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 148 | 1.010 |
Why?
| | Cell Communication | 1 | 2018 | 280 | 0.570 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 424 | 0.560 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2014 | 35 | 0.480 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2014 | 193 | 0.420 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 617 | 0.390 |
Why?
| | Xenograft Model Antitumor Assays | 8 | 2020 | 703 | 0.350 |
Why?
| | Antineoplastic Agents | 3 | 2016 | 1891 | 0.300 |
Why?
| | Hedgehog Proteins | 3 | 2015 | 172 | 0.240 |
Why?
| | Mice, Nude | 4 | 2018 | 639 | 0.220 |
Why?
| | Hyaluronan Receptors | 2 | 2020 | 91 | 0.210 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 138 | 0.200 |
Why?
| | Neoplasms | 1 | 2014 | 2114 | 0.180 |
Why?
| | Mice | 12 | 2023 | 15085 | 0.180 |
Why?
| | Cetuximab | 3 | 2015 | 90 | 0.180 |
Why?
| | SOXB1 Transcription Factors | 2 | 2020 | 60 | 0.180 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2020 | 44 | 0.170 |
Why?
| | Animals | 15 | 2023 | 32158 | 0.170 |
Why?
| | Tumor Cells, Cultured | 2 | 2018 | 850 | 0.170 |
Why?
| | Stem Cell Niche | 1 | 2019 | 43 | 0.170 |
Why?
| | Mouth Neoplasms | 1 | 2019 | 70 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 666 | 0.160 |
Why?
| | Cell Line, Tumor | 7 | 2020 | 2749 | 0.160 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 37 | 0.160 |
Why?
| | Peptides, Cyclic | 1 | 2020 | 262 | 0.150 |
Why?
| | Salivary Gland Neoplasms | 1 | 2018 | 31 | 0.150 |
Why?
| | Disease Models, Animal | 4 | 2020 | 3587 | 0.150 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 445 | 0.150 |
Why?
| | Cell Proliferation | 3 | 2019 | 2196 | 0.140 |
Why?
| | Veratrum Alkaloids | 2 | 2014 | 17 | 0.140 |
Why?
| | Immunotherapy | 1 | 2020 | 481 | 0.140 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1360 | 0.140 |
Why?
| | ErbB Receptors | 3 | 2016 | 557 | 0.130 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 356 | 0.130 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2020 | 862 | 0.120 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 11 | 0.120 |
Why?
| | Replication Protein A | 1 | 2014 | 11 | 0.120 |
Why?
| | Stromal Cells | 1 | 2014 | 97 | 0.120 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2014 | 41 | 0.120 |
Why?
| | Homologous Recombination | 1 | 2014 | 21 | 0.120 |
Why?
| | Melanoma | 1 | 2020 | 649 | 0.120 |
Why?
| | Radiation Tolerance | 1 | 2014 | 92 | 0.110 |
Why?
| | Immunophenotyping | 3 | 2019 | 273 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 524 | 0.110 |
Why?
| | Leukemia, Radiation-Induced | 1 | 2012 | 4 | 0.110 |
Why?
| | Sulfones | 1 | 2013 | 98 | 0.110 |
Why?
| | DNA Replication | 1 | 2014 | 204 | 0.110 |
Why?
| | Microsatellite Instability | 1 | 2012 | 32 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1143 | 0.110 |
Why?
| | Glycine | 1 | 2013 | 156 | 0.100 |
Why?
| | Gamma Rays | 1 | 2012 | 47 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 2 | 2013 | 609 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1045 | 0.100 |
Why?
| | Mice, Inbred NOD | 2 | 2023 | 562 | 0.090 |
Why?
| | Humans | 16 | 2023 | 115859 | 0.090 |
Why?
| | Trans-Activators | 1 | 2012 | 369 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 332 | 0.090 |
Why?
| | Nuclear Proteins | 1 | 2014 | 595 | 0.090 |
Why?
| | Apoptosis | 1 | 2018 | 2377 | 0.090 |
Why?
| | Signal Transduction | 4 | 2016 | 4527 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2016 | 2581 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1644 | 0.080 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2020 | 130 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2012 | 532 | 0.070 |
Why?
| | Papillomaviridae | 2 | 2016 | 100 | 0.060 |
Why?
| | Mutation | 4 | 2018 | 3371 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2020 | 555 | 0.060 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 361 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 193 | 0.050 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 23 | 0.050 |
Why?
| | Feedback, Physiological | 1 | 2020 | 74 | 0.040 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 246 | 0.040 |
Why?
| | Heterografts | 1 | 2019 | 119 | 0.040 |
Why?
| | Biomarkers | 2 | 2019 | 3474 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 190 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2020 | 187 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 192 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 188 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 377 | 0.040 |
Why?
| | Monocytes | 1 | 2020 | 504 | 0.040 |
Why?
| | DNA Damage | 1 | 2020 | 356 | 0.040 |
Why?
| | Cell Cycle | 1 | 2020 | 546 | 0.040 |
Why?
| | Retinal Dehydrogenase | 1 | 2016 | 38 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 177 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 57 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 235 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1177 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2016 | 129 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 182 | 0.030 |
Why?
| | Female | 5 | 2020 | 60070 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 175 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 950 | 0.030 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2014 | 21 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 37 | 0.030 |
Why?
| | Cell Division | 1 | 2016 | 760 | 0.030 |
Why?
| | Checkpoint Kinase 1 | 1 | 2014 | 28 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 312 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 390 | 0.030 |
Why?
| | Cricetulus | 1 | 2014 | 99 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 63 | 0.030 |
Why?
| | CHO Cells | 1 | 2014 | 140 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 621 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 443 | 0.030 |
Why?
| | Cricetinae | 1 | 2014 | 260 | 0.030 |
Why?
| | Serine | 1 | 2014 | 125 | 0.030 |
Why?
| | Receptor, Notch2 | 1 | 2013 | 14 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 20 | 0.030 |
Why?
| | Gonanes | 1 | 2013 | 27 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 76 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 168 | 0.030 |
Why?
| | Alphapapillomavirus | 1 | 2013 | 36 | 0.030 |
Why?
| | Cesium Radioisotopes | 1 | 2012 | 1 | 0.030 |
Why?
| | Linear Energy Transfer | 1 | 2012 | 3 | 0.030 |
Why?
| | Chromatids | 1 | 2012 | 8 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 59 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2012 | 56 | 0.030 |
Why?
| | Gene Silencing | 1 | 2013 | 176 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2018 | 2608 | 0.030 |
Why?
| | Chromosome Aberrations | 1 | 2012 | 136 | 0.030 |
Why?
| | Protein Kinases | 1 | 2014 | 306 | 0.030 |
Why?
| | Male | 4 | 2020 | 56103 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 824 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2012 | 310 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1550 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1379 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 742 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2423 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2012 | 181 | 0.020 |
Why?
| | Iron | 1 | 2012 | 235 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1442 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1153 | 0.020 |
Why?
| | Papillomavirus Infections | 1 | 2013 | 258 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1562 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 540 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 638 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 27078 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1535 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2015 | 9163 | 0.010 |
Why?
| | Aged | 1 | 2019 | 19292 | 0.010 |
Why?
|
|
Le's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|